Impact of Cold Air Exposure on Croup Symptoms
Outdoor Cold Air Exposure Versus Room Temperature for Croup Symptoms in Pediatric Emergency Departments: a Randomized Controlled Trial
1 other identifier
interventional
118
0 countries
N/A
Brief Summary
The goal of the present randomised controlled clinical trial is to compare the efficacy of a 30-minute exposition to cold, atmospheric, outdoor air on the severity of croup symptoms with exposition to indoor room air in children with mild to moderate croup receiving a single dose of dexamethasone during winter croup outbreaks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedFirst Submitted
Initial submission to the registry
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
December 29, 2022
CompletedJanuary 11, 2023
January 1, 2023
4.6 years
December 12, 2022
January 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Westley croup score at 30 minutes
The primary outcome is the proportion of patients showing an decrease of at least 2 points in their Westley croup score at 30 minutes from triage. The 5-item Westley croup score uses a 17 points ordinal scale to assess level of consciousness (5 points), cyanosis (5 points), stridor (2 points), air entry (2 points), and chest wall retractions (3 points). Mild croup is defined as a WCS \< or = 2, moderate 3-5, severe 6-11, and impending respiratory failure or \>12.
at 30 minutes
Secondary Outcomes (7)
Westley croup score at 60 minutes
at 60 minutes
Pulse oxymetry
at 0 min, at 30 and at 60 minutes from enrolment at triage
Respiratory rate
at 0 min, at 30 and at 60 minutes from enrolment at triage
Heart rate
at 0 min, at 30 and at 60 minutes from enrolment at triage
Telephone Outpatient derived score
at the time of leaving home for the pediatric emergency department visit; at 0 min on pediatric emergency department arrival (i.e., at triage); at day 7 from the initial visit
- +2 more secondary outcomes
Study Arms (2)
Exposition group
EXPERIMENTALOutdoor cold air exposure (\<10°C or \<50°F) for 30 minutes. On completion of the intervention, participants remained under observation at indoor ambient air from 30 minutes to 60 minutes from the intervention.
Control group
NO INTERVENTIONIndoor ambient air exposure (24-25°C or 75-77°C). Participants remained under observation at indoor ambient until 60 minutes from triage.
Interventions
Exposure to outdoor cold air (\<10°C or \<50°F, intervention group) for 30 minutes. On completion of the intervention, participants remained under observation at indoor ambient air from 30 minutes to 60 minutes from the intervention.
Eligibility Criteria
You may qualify if:
- \- children from 3 months to 10 years with clinical signs of croup and Westley croup score \> or =2
You may not qualify if:
- Need for close monitoring
- Need for nebulized epinephrine
- History or physical examination suggesting any other diagnosis
- Chronic respiratory disease (except asthma)
- Underlying airway abnormalities
- Immunodeficiency
- Contraindication to steroids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Gates A, Gates M, Vandermeer B, Johnson C, Hartling L, Johnson DW, Klassen TP. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD001955. doi: 10.1002/14651858.CD001955.pub4.
PMID: 30133690BACKGROUNDHanna J, Brauer PR, Morse E, Berson E, Mehra S. Epidemiological analysis of croup in the emergency department using two national datasets. Int J Pediatr Otorhinolaryngol. 2019 Nov;126:109641. doi: 10.1016/j.ijporl.2019.109641. Epub 2019 Aug 13.
PMID: 31442871RESULTJohnson DW. Croup. BMJ Clin Evid. 2014 Sep 29;2014:0321.
PMID: 25263284RESULTMoore M, Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002870. doi: 10.1002/14651858.CD002870.pub2.
PMID: 16855994RESULTBjornson CL, Williamson J, Johnson DW. Telephone Out Patient Score: The Derivation and Validation of a Telephone Follow-up Assessment Tool for Use in Clinical Research in Children With Croup. Pediatr Emerg Care. 2016 May;32(5):290-7. doi: 10.1097/PEC.0000000000000796.
PMID: 27139290RESULTSiebert JN, Salomon C, Taddeo I, Gervaix A, Combescure C, Lacroix L. Outdoor Cold Air Versus Room Temperature Exposure for Croup Symptoms: A Randomized Controlled Trial. Pediatrics. 2023 Sep 1;152(3):e2023061365. doi: 10.1542/peds.2023-061365.
PMID: 37525974DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johan Siebert, MD
University Hospitals of Geneva
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Head of the Pediatric Emergency Department
Study Record Dates
First Submitted
December 12, 2022
First Posted
December 29, 2022
Study Start
November 1, 2016
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
January 11, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 6 month to 5 years after publication of results.
- Access Criteria
- Data will be made available from the corresponding author upon approval of a proposal and after a signed data access agreement. Deidentified participant data will be made available to qualified external researchers who will use them according to their Institutional Review Board. Data will be made available for a specified research purpose. The request proposal should include participation of a statistician.
Deidentified Individual Participant Data will be available from the corresponding author upon reasonable request, recognizing that these data will only provide results for the current trial and not for future trials. Only deidentified/anonymized data will be shared.